In SEC Filing Ackman Says Allergan is "Sandbagging"Mark Melin
William Ackman’s Pershing Square recently filed a Securities and Exchange Commission 14A form regarding statements he made about Allergan, Inc. (NYSE:AGN) in his recent investor letter.
Ackman praises his buddy Bill Johnson for working with a cancer research firm
The SEC’s 14A form is typically used to provide shareholders information to make “informed” votes at shareholder meetings. Ackman starts Sign up here
If you are subscribed and having an account error please clear cache and cookies if that does not work email firstname.lastname@example.org or click chat